Blaine, MN, United States of America

Adam J Rivard

This inventor holds 20 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Implantable Medical Devices. Top assignees: Medtronic, Inc., Cardiac Pacemakers, Inc., Medtronic Xomed, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam J Rivard. Retrieved from https://idiyas.com/inventor/adam-j-rivard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 75.0

 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Implantable Leads
Medical Devices
Obstructive Sleep Apnea
Lead Extensions
Stimulation Therapy
Connector Assemblies
Implant Systems
Compression Devices
Anchoring Mechanisms
Tongue Movement
Electrical Contacts
Implantation Tools
20 patents (USPTO):Explore Patents

Title: The Innovative Mind of Adam J Rivard

Introduction: Adam J Rivard, an accomplished inventor based in Blaine, MN, holds an impressive portfolio of 18 patents. His inventions primarily focus on advancements in medical technology, particularly in the treatment of obstructive sleep apnea (OSA). Rivard's work exemplifies the intersection of innovation and healthcare, showcasing his commitment to improving patient outcomes through effective solutions.

Latest Patents: Among Rivard's latest patents are groundbreaking systems for treating obstructive sleep apnea. One notable invention is a stimulation therapy that utilizes compound muscle action potential (CMAP) signals. This medical system is designed to deliver electrical stimulation signals to a patient’s tongue, helping to address the symptoms of OSA. The system includes therapy delivery circuitry, sensing circuitry, and processing circuitry, which collaboratively work to optimize therapeutic stimulation parameters based on the detected CMAP signals.

Another significant patent involves a multi-device therapy system for OSA treatment. This groundbreaking approach entails a medical device equipped with therapy delivery circuitry and a set of electrodes placed near the hypoglossal nerves within the tongue. The device delivers electrical stimulation to advance the tongue, thereby preventing airway obstruction during sleep. The communication between devices increases the effectiveness of treatment, leading to improved health outcomes for patients.

Career Highlights: Rivard has made substantial contributions to the field of medical technology through his career with notable organizations. He has worked at Medtronic, Inc., a leading company in medical devices and therapies, where he gained valuable experience in developing innovative solutions. Additionally, he contributed his expertise at Cardiac Pacemakers, Inc., where he further honed his skills in medical device technology.

Collaborations: Throughout his career, Rivard has collaborated with esteemed colleagues, including Scott M Hanson and Joseph P Ricci. These partnerships have allowed him to enhance his inventions and contribute to significant advancements in the field of medical engineering.

Conclusion: Adam J Rivard stands out as a prominent inventor in the medical technology arena. With 18 patents to his name, his innovations, particularly in the treatment of obstructive sleep apnea, demonstrate his dedication to improving quality of life for patients. Rivard's work continues to inspire future innovations that hold the promise of better health outcomes for individuals suffering from OSA and other similar conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…